After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
JANX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Janux Therapeutics Inc is $1.53B. A total of 0.66 million shares were traded on the day, compared to an average of 846.85K shares.
In the most recent transaction, Meyer Andrew Hollman sold 3,333 shares of JANX for 32.03 per share on May 01 ’25. After the transaction, the Chief Business Officer now owns 82,139 company shares. In a previous transaction on May 01 ’25, ANDREW MEYER bought 3,333 shares at 33.20 per share.
Among the insiders who sold shares, Meyer Andrew Hollman disposed of 3,334 shares on Apr 21 ’25 at a per-share price of $30.00. This resulted in the Chief Business Officer holding 82,139 shares of JANX after the transaction. In another insider transaction, ANDREW MEYER bought 3,334 shares at $29.69 per share on Apr 21 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, JANX has a high of $71.71 and a low of $21.97.
As of this writing, JANX has an earnings estimate of -$0.63 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.43 per share and a lower estimate of -$1.02. The company reported an EPS of -$0.51 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. JANX’s latest balance sheet shows that the firm has $374.96M in Cash & Short Term Investments as of fiscal 2021. There were $194.00k in debt and $12.80M in liabilities at the time. Its Book Value Per Share was $16.70, while its Total Shareholder’s Equity was $366.33M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JANX is Buy with a score of 4.62.
